Project Number EUJPND-AlzSocUK-Edison-1930 Agency/Funding Organization Alzheimer's Society UK Funding Year 2016 View Full Project Details for Effect of GLP1 analogue, Liraglutide on cerebral glucose metabolism and microglial activation in Alzheimer's disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 10. Metabolism and Bioenergetics f. CNS Glucose Researcher and Organization Principal Investigator Edison, Paul Principal Investigator First Name Paul Principal Investigator Last Name Edison Awardee Organization United Kingdom Contact PI Country United Kingdom Project Detail FY Overall Cost $96,612 Funding Organization Agency/Funding Organization Alzheimer's Society UK Funding Organization Country United Kingdom Special Initiative EU Joint Programme - Neurodegenerative Disease Research - Research Mapping (2016)
